Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

What is the optimal therapeutic approach in high-risk endometrial cancer?

Can the molecular classification guide adjuvant medical treatment?

Date

12 Sep 2022

Session

What is the optimal therapeutic approach in high-risk endometrial cancer?

Topics

Tumour Site

Endometrial Cancer

Presenters

Alexandra Leary

Authors

A. Leary

Author affiliations

  • Medicine Dept., Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Presentation of case/condition 

Presenter: Alexandra Leary

Session: What is the optimal therapeutic approach in high-risk endometrial cancer?

Resources:

Slides

Webcast

The role of surgery

Presenter: Christian Marth

Session: What is the optimal therapeutic approach in high-risk endometrial cancer?

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: What is the optimal therapeutic approach in high-risk endometrial cancer?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.